{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:20Z","timestamp":1793382980968,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sepsis, one of the leading causes of death in critically ill patients, is characterized by multiple organ dysfunction due to a dysregulated immune response to infection. Caregivers closely monitor patients\u2019 organ function indicators in the intensive care unit,which is essential for the early identification and management of organ dysfunction cauxsd by sepsis. Hence, we investigated the effects of CSN6 on sepsis and its underlying mechanism. RAW264.7 cell inducted with lipopolysaccharide (LPS) and adenosine triphosphate (ATP). CSN6 protein expression increased in an in vitro model of sepsis. We collected samples from 10 sepsis patients (It was collected under strict compliance with ethical norms and nursing procedures) and performed single-cell analysis for CSN6 expression. CSN6 aggravated macrophage inflammation in an in vitro model of sepsis. CSN6 aggravated macrophage ferroptosis in an in vitro model of sepsis. CSN6 aggravates mitochondrial damage in an in vitro model of sepsis. CSN6 induces MIF expression in macrophages in an in vitro model of sepsis. MIF inhibitors reduced the effects of CSN6 on inflammation and ferroptosis in an in vitro sepsis model. CSN6 protein at 11-ARG, 21-ARG, 31-LEU, and 32-ASP linked to MIF protein at 280-ASN and 366-SER. In conclusion, CSN6 appears to aggravate inflammation in macrophages in a sepsis model via MIF signaling. This finding suggests that future therapeutic strategier targeting the CSN6 and MIF pathways may require nurses to closely monitor changes in inflammatory responses and potential treatment side effecta at the bedside. Further research involving in vivo models, such as examining CSN6 and MIF expression levels in macrophages or monocytes from sepsis and control mice, is essential to fully confirm these findings and establish the therapeutic potential of targeting the CSN6\/MIF axis in sepsis. The nursing research team plays a key role in translating basic research findings into clinical practice,including the developpment of early warning tools and individualized management programs based on these biomarkers.<\/jats:p>","DOI":"10.1038\/s41598-025-07339-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:56:03Z","timestamp":1751378163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CSN6\u00a0aggravates inflammation and Myocardial injury in macrophage of sepsis model by MIF"],"prefix":"10.1038","volume":"15","author":[{"given":"Qianying","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"7339_CR1","doi-asserted-by":"publisher","first-page":"e14652","DOI":"10.1111\/iwj.14652","volume":"21","author":"K Guo","year":"2024","unstructured":"Guo, K. et al. Developing an early warning system for detecting sepsis in patients with trauma. Int. Wound. J. 21(1), e14652 (2024).","journal-title":"Int. Wound. J."},{"key":"7339_CR2","first-page":"314","volume":"310","author":"L Li","year":"2024","unstructured":"Li, L. et al. Blood Culture Ordering After Sepsis Alerts and Subsequent Patient Outcomes: An Electronic Health Record-Based Study. Stud Health Technol. Inform. 310, 314\u2013318 (2024).","journal-title":"Stud Health Technol. Inform."},{"key":"7339_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijregi.2023.12.002","volume":"10","author":"HA Raza","year":"2024","unstructured":"Raza, H. A. et al. Review of sepsis in Pakistan: how far have we come?. IJID Reg. 10, 108\u2013113 (2024).","journal-title":"IJID Reg."},{"issue":"1","key":"7339_CR4","doi-asserted-by":"publisher","first-page":"e1138","DOI":"10.1002\/iid3.1138","volume":"12","author":"G Chen","year":"2024","unstructured":"Chen, G. et al. An integrative model with HLA-DR, CD64, and PD-1 for the diagnostic and prognostic evaluation of sepsis. Immun. Inflamm. Dis. 12(1), e1138 (2024).","journal-title":"Immun. Inflamm. Dis."},{"key":"7339_CR5","doi-asserted-by":"crossref","unstructured":"Chen, M., et al., Songorine ameliorates LPS-induced sepsis cardiomyopathy by Wnt\/\u03b2-catenin signaling pathway-mediated mitochondrial biosynthesis. Naunyn Schmiedebergs Arch. Pharmacol., (2023).","DOI":"10.1007\/s00210-023-02897-5"},{"key":"7339_CR6","unstructured":"Fang, Z., et al., Astilbin protects from sepsis-induced cardiac injury through the NRF2\/HO-1 and TLR4\/NF-\u03baB pathway. Phytother. Res., (2023)."},{"issue":"1","key":"7339_CR7","doi-asserted-by":"publisher","first-page":"e10609","DOI":"10.1002\/btm2.10609","volume":"9","author":"X Ge","year":"2024","unstructured":"Ge, X. et al. Extracellular vesicles from normal tissues orchestrate the homeostasis of macrophages and attenuate inflammatory injury of sepsis. Bioeng. Transl. Med. 9(1), e10609 (2024).","journal-title":"Bioeng. Transl. Med."},{"key":"7339_CR8","doi-asserted-by":"crossref","unstructured":"Ambriz-Alarc\u00f3n, M.A., et al., Acute Myocardial Injury Assessed by High-Sensitivity Cardiac Troponin I Levels in Adult Patients with Early Sepsis at a Tertiary Referral Center in Mexico: An Exploratory Study. J. Cardiovasc. Dev. Dis., (2024).","DOI":"10.3390\/jcdd11010028"},{"issue":"12","key":"7339_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1080\/14728222.2016.1251582","volume":"20","author":"J Bloom","year":"2016","unstructured":"Bloom, J., Sun, S. & Al-Abed, Y. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development. Expert. Opin. Ther. Targets 20(12), 1463\u20131475 (2016).","journal-title":"Expert. Opin. Ther. Targets"},{"issue":"14","key":"7339_CR10","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2174\/1389557515666150203143317","volume":"14","author":"G Grieb","year":"2014","unstructured":"Grieb, G. et al. MIF and CD74 - suitability as clinical biomarkers. Mini Rev. Med. Chem. 14(14), 1125\u20131131 (2014).","journal-title":"Mini Rev. Med. Chem."},{"key":"7339_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","volume":"57","author":"SS Jankauskas","year":"2019","unstructured":"Jankauskas, S. S. et al. Evolving complexity of MIF signaling. Cell Signal 57, 76\u201388 (2019).","journal-title":"Cell Signal"},{"issue":"4","key":"7339_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1358\/dnp.2010.23.4.1453629","volume":"23","author":"G Grieb","year":"2010","unstructured":"Grieb, G. et al. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug. News Perspect. 23(4), 257\u2013264 (2010).","journal-title":"Drug. News Perspect."},{"issue":"1","key":"7339_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4155\/fmc.10.281","volume":"3","author":"Y Al-Abed","year":"2011","unstructured":"Al-Abed, Y. & VanPatten, S. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic. Future Med. Chem. 3(1), 45\u201363 (2011).","journal-title":"Future Med. Chem."},{"issue":"10","key":"7339_CR14","first-page":"5419","volume":"24","author":"WY Gao","year":"2020","unstructured":"Gao, W. Y. et al. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2. Eur. Rev. Med. Pharmacol. Sci. 24(10), 5419\u20135428 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"7339_CR15","first-page":"645","volume":"35","author":"J Hou","year":"2020","unstructured":"Hou, J. & Cui, H. CSN6: a promising target for cancer prevention and therapy. Histol Histopathol. 35(7), 645\u2013652 (2020).","journal-title":"Histol Histopathol."},{"issue":"10","key":"7339_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2174\/1871520619666190408142131","volume":"19","author":"Z Mao","year":"2019","unstructured":"Mao, Z., Chen, C. & Pei, D. S. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress. Anticancer Agents Med. Chem. 19(10), 1198\u20131204 (2019).","journal-title":"Anticancer Agents Med. Chem."},{"issue":"1","key":"7339_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12874-023-02138-6","volume":"24","author":"Y Tang","year":"2024","unstructured":"Tang, Y., Zhang, Y. & Li, J. A time series driven model for early sepsis prediction based on transformer module. BMC Med. Res. Methodol. 24(1), 23 (2024).","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"7339_CR18","doi-asserted-by":"publisher","first-page":"e0296456","DOI":"10.1371\/journal.pone.0296456","volume":"19","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. A nomogram for predicting mortality risk within 30 days in sepsis patients admitted in the emergency department: A retrospective analysis. PLoS ONE 19(1), e0296456 (2024).","journal-title":"PLoS ONE"},{"key":"7339_CR19","doi-asserted-by":"publisher","first-page":"111382","DOI":"10.1016\/j.intimp.2023.111382","volume":"127","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Activation of sigma-1 receptor ameliorates sepsis-induced myocardial injury by mediating the Nrf2\/HO1 signaling pathway to attenuate mitochondrial oxidative stress. Int. Immunopharmacol. 127, 111382 (2024).","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"7339_CR20","doi-asserted-by":"publisher","first-page":"e22595","DOI":"10.1096\/fj.202200434RR","volume":"36","author":"Y Wen","year":"2022","unstructured":"Wen, Y. et al. TNF-\u03b1-dependent lung inflammation upregulates PD-L1 in monocyte-derived macrophages to contribute to lung tumorigenesis. Faseb J. 36(11), e22595 (2022).","journal-title":"Faseb J."},{"key":"7339_CR21","unstructured":"Qin, S., et al., Annexin-A1 short peptide alleviates septic myocardial injury by upregulating SIRT3 and inhibiting myocardial cell apoptosis. Histol. Histopathol. (2023)."},{"key":"7339_CR22","doi-asserted-by":"publisher","first-page":"155277","DOI":"10.1016\/j.phymed.2023.155277","volume":"123","author":"F Tang","year":"2024","unstructured":"Tang, F. et al. Ameliorative effect of anisodamine (654\u20131\/654-2) against myocardial dysfunction induced by septic shock via the NF-\u03baB\/NLRP-3 or the PI3K-AKT\/NF-\u03baB pathway. Phytomedicine 123, 155277 (2024).","journal-title":"Phytomedicine"},{"issue":"1","key":"7339_CR23","doi-asserted-by":"publisher","first-page":"113905","DOI":"10.1016\/j.yexcr.2023.113905","volume":"435","author":"LJ Xu","year":"2023","unstructured":"Xu, L. J. et al. SP1-stimulated miR-208a-5p aggravates sepsis-induced myocardial injury via targeting XIAP. Exp. Cell Res. 435(1), 113905 (2023).","journal-title":"Exp. Cell Res."},{"key":"7339_CR24","doi-asserted-by":"publisher","first-page":"1309719","DOI":"10.3389\/fcell.2023.1309719","volume":"11","author":"AB Liu","year":"2023","unstructured":"Liu, A. B. et al. Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction. Front Cell. Dev. Biol. 11, 1309719 (2023).","journal-title":"Front Cell. Dev. Biol."},{"issue":"1","key":"7339_CR25","doi-asserted-by":"publisher","first-page":"112245","DOI":"10.1016\/j.yexcr.2020.112245","volume":"396","author":"ZL Mei","year":"2020","unstructured":"Mei, Z. L. et al. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2. Exp. Cell Res. 396(1), 112245 (2020).","journal-title":"Exp. Cell Res."},{"key":"7339_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2022.05.018","volume":"187","author":"M Sun","year":"2022","unstructured":"Sun, M. et al. Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway. Free Radic. Biol Med 187, 141\u2013157 (2022).","journal-title":"Free Radic. Biol Med"},{"issue":"Pt A","key":"7339_CR27","doi-asserted-by":"publisher","first-page":"111038","DOI":"10.1016\/j.intimp.2023.111038","volume":"125","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. Dapagliflozin attenuates the vulnerability to atrial fibrillation in rats with lipopolysaccharide-induced myocardial injury. Int. Immunopharmacol. 125(Pt A), 111038 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"7339_CR28","doi-asserted-by":"crossref","unstructured":"Pu, Z., et al., The effects and mechanisms of the anti-COVID-19 traditional Chinese medicine, Dehydroandrographolide from Andrographis paniculata (Burm.f.) Wall, on acute lung injury by the inhibition of NLRP3-mediated pyroptosis. Phytomedicine, 114: p. 154753. (2023).","DOI":"10.1016\/j.phymed.2023.154753"},{"issue":"2","key":"7339_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/72230","volume":"6","author":"TR Martin","year":"2000","unstructured":"Martin, T. R. MIF mediation of sepsis. Nat. Med. 6(2), 140\u2013141 (2000).","journal-title":"Nat. Med."},{"issue":"6","key":"7339_CR30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/09680519010070061101","volume":"7","author":"T Roger","year":"2001","unstructured":"Roger, T., Glauser, M. P. & Calandra, T. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. J. Endotoxin. Res. 7(6), 456\u2013460 (2001).","journal-title":"J. Endotoxin. Res."},{"key":"7339_CR31","doi-asserted-by":"crossref","unstructured":"Tilstam, P.V., et al., MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model. J. Clin. Invest., 131(23). (2021).","DOI":"10.1172\/JCI127171"},{"issue":"11","key":"7339_CR32","doi-asserted-by":"publisher","first-page":"e22601","DOI":"10.1096\/fj.202201213R","volume":"36","author":"C Zan","year":"2022","unstructured":"Zan, C. et al. D-dopachrome tautomerase in cardiovascular and inflammatory diseases-A new kid on the block or just another MIF?. Faseb J. 36(11), e22601 (2022).","journal-title":"Faseb J."},{"issue":"1","key":"7339_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41420-022-00859-z","volume":"8","author":"T Li","year":"2022","unstructured":"Li, T. et al. Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI. Cell Death Discov. 8(1), 61 (2022).","journal-title":"Cell Death Discov."},{"issue":"7","key":"7339_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.febslet.2005.01.080","volume":"579","author":"A Burger-Kentischer","year":"2005","unstructured":"Burger-Kentischer, A. et al. Binding of JAB1\/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett. 579(7), 1693\u20131701 (2005).","journal-title":"FEBS Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07339-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:56:06Z","timestamp":1751378166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07339-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7339"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07339-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4398366\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21527"}}